Sort
64,565 grants matching “drug discovery”
Deciphering Enzyme Specificity: Theoretical and Computational Approaches
$484,314Patricia Clement Babbitt · University Of Illinois At Urbana-Champaign · P01 · FY2011 · GM
REPEAT-CONTAINING RNA BINDING PROTEINS OF TRYPANOSOMES
$484,307Inna Afasizheva · Boston University Medical Campus · R01 · FY2022 · AI
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
$484,268Barry Coller · Rockefeller University · UL1 · FY2018 · TR
Discovery of Oxaboroles as New Antimalarial Agents
$484,268Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2013 · AI
Neural hierarchy in the modulation of ingestive behavior
$484,243Harvey J Grill · University Of Pennsylvania · R01 · FY2016 · DK
Molecular Imaging of Cardiac Pluripotent Stem Cells
$484,238Joseph C Wu · Stanford University · R01 · FY2017 · HL
Chemistry principles applied to the development of new catalytic C-H bond functionalization methods for amine and heterocycle preparation and to the design, synthesis and use of new enzyme inhibitors
$484,233Jonathan A. Ellman · Yale University · R35 · FY2017 · GM
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis
$484,198Mei-Zhen Cui · University Of Texas Of The Permian Basin · R01 · FY2021 · HL
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis
$484,198Mei-Zhen Cui · University Of Texas Of The Permian Basin · R01 · FY2020 · HL
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis
$484,198Mei-Zhen Cui · University Of Texas Of The Permian Basin · R01 · FY2023 · HL
The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis
$484,198Mei-Zhen Cui · University Of Texas Of The Permian Basin · R01 · FY2022 · HL
Personalized therapy for AATD-associated liver disease via IPS modeling
$484,182Andrew A Wilson · Boston University Medical Campus · R01 · FY2016 · DK
Clinical and Translational Science Center
$484,142Julianne L Imperato-McGinley · Weill Medical Coll Of Cornell Univ · KL2 · FY2014 · TR
Pathology and Biobanking
$484,087George Miles · Baylor College Of Medicine · P50 · FY2022 · CA
Pathology and Biobanking
$484,075George Miles · Baylor College Of Medicine · P50 · FY2021 · CA
Design & Synthesis of Nonpeptide Protease Inhibitors
$484,067Arun K Ghosh · Purdue University · R37 · FY2020 · AI
Integrative analysis and modeling of human immune responses and pathologies
$484,009John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Drug and drug-target identification for mitochondrial diseases using random shRNA selection
$484,000Robert B Wilson · Children'S Hosp Of Philadelphia · R21 · FY2020 · NS
REPEAT-CONTAINING RNA BINDING PROTEINS OF TRYPANOSOMES
$483,999Inna Afasizheva · Boston University Medical Campus · R01 · FY2023 · AI
Plant Anti-HIV Agents
$483,933Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
Plant Anti-HIV Agents
$483,933Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2015 · AI
Plant Anti-HIV Agents
$483,933Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2016 · AI
Plant Anti-HIV Agents
$483,933Kuo-Hsiung Lee · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AI
Coordinate Regulation of Bacterial Virulence Factors
$483,904John J Mekalanos · Harvard Medical School · R01 · FY2013 · AI
Development of high-throughput, high-sensitivity EPR sample handling capabilities for biomedical research
$483,900Candice S Klug · Medical College Of Wisconsin · R01 · FY2021 · GM